1994
DOI: 10.1254/jjp.64.109
|View full text |Cite
|
Sign up to set email alerts
|

Antiemetic Effects of Serotonergic 5-HT1A-Receptor Agonists in Suncus Murinus

Abstract: ABSTRACT-The antiemetic effects of six serotonergic 5-HTIA-receptor agonists, 8-hydroxy-2-(di-n-pro pylamino)tetrarin (8-OH-DPAT), 4-{4-[4-(2-pyrimidinyl)piperazin-l-yl]butyl}-2,3,4,5-tetrahydro-l,4-benzo xazepine-3,5-dione (SUN8399), buspirone, gepirone, ipsapirone and tandospirone, against motion sickness were investigated in Suncus murinus. Subcutaneous injection of all six agonists completely and dose-dependently suppressed motion-induced emesis. Pretreatment with 8-OH-DPAT or SUN8399 dose dependently inhi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
29
0

Year Published

1995
1995
2016
2016

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 73 publications
(33 citation statements)
references
References 12 publications
1
29
0
Order By: Relevance
“…Triptans may evoke analgesic anti-migraine activity in the trigeminal nucleus caudalis, and anti-emetic effects in the NTS, by acting on the numerous 5-HT 1 receptor sites in these locations (Pascual, del Arco, Romon, del Omo, Castro and Pazos, 1996;Hoskin et al, 2004). Serotonin prevents motioninduced emesis in animals (Javid and Naylor, 2006;Okada, Saito and Matsuki, 1996), and 5-HT 1A agonists inhibit vomiting during motion sickness in cats (Lucot, 1989;Yates, Miller and Lucot, 1998) and the Asian musk shrew (Okada, Torii, Saito and Matsuki, 1994). However, findings in animal research do not necessarily extrapolate to clinical efficacy in humans (Reid, Sciberras, Gertz, Reinhardt, Lui, Golding and Stott, 1998;Hasler, 1999;Peroutka, 2005).…”
Section: Serotonin Migraine and Motion Sicknessmentioning
confidence: 99%
“…Triptans may evoke analgesic anti-migraine activity in the trigeminal nucleus caudalis, and anti-emetic effects in the NTS, by acting on the numerous 5-HT 1 receptor sites in these locations (Pascual, del Arco, Romon, del Omo, Castro and Pazos, 1996;Hoskin et al, 2004). Serotonin prevents motioninduced emesis in animals (Javid and Naylor, 2006;Okada, Saito and Matsuki, 1996), and 5-HT 1A agonists inhibit vomiting during motion sickness in cats (Lucot, 1989;Yates, Miller and Lucot, 1998) and the Asian musk shrew (Okada, Torii, Saito and Matsuki, 1994). However, findings in animal research do not necessarily extrapolate to clinical efficacy in humans (Reid, Sciberras, Gertz, Reinhardt, Lui, Golding and Stott, 1998;Hasler, 1999;Peroutka, 2005).…”
Section: Serotonin Migraine and Motion Sicknessmentioning
confidence: 99%
“…Selective antagonists for the 5-HT3 receptor inhibit emesis induced by cancer chemotherapeutic agents, such as cisplatin, in ferrets (Costall et al, 1986), dogs (Smith et al, 1986), cats (Lucot, 1989) and Suncus (Torii et al, 1991a) and these antagonists have been used clinically. It has also been reported that 5-HT,A receptor agonists can block emesis induced by motion and several emetic drugs in cats (Lucot & Crampton, 1989) and Suncus (Okada et al, 1994).…”
Section: Introduction Methodsmentioning
confidence: 89%
“…In cats, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and buspirone suppress vomiting elicited by motion, cisplatin and xylazine (Lucot & Crampton, 1989). In Suncus, several 5-HTA receptor agonists inhibited emesis not only elicited by cisplatin but also by other stimuli (Okada et al, 1994). However, it is not likely that the antiemetic effect of DOI is mediated via 5-HTA receptors, since this compound has very little affinity for 5-HTIA receptors (Hoyer, 1988a).…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies in laboratory animals indicate that 5-HTlA receptor agonists (buspirone, 8-OH-DPAT, flesinoxan, genpirone) have antiemetic activity against emetic stimuli acting via different pathways (Lucot andCrampton, 1987, 1989;Milano and Gregot, 1992;Okada et al, 1994). High concentrations of 5-HTlA binding sites and of receptor mRNA have been found in the nucleus tractus solitarius, an important brain area in the control of emesis (Lucot, 1992).…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies indicate that, in addition to 5-HT3 receptors, other serotonin receptor subtypes may play a role in emesis. In laboratory animals, activation of 5-HTlA receptors by a single dose of 8-hydroxy-2-(di-n-propyl amino)tetralin(8-OH-DPAT), buspirone or other 5-HTIA agonists suppresses emesis induced by motion sickness, cisplatin, ac2-adrenergic receptor agonists, nicotine, veratrine, copper sulphate or stimulation of vagal afferents (Lucot andCrampton, 1987, 1989;Milano and Gregot, 1992;Okada et al, 1994). The antiemetic effects of 5-HTlA receptor agonists have not been explored in humans.…”
mentioning
confidence: 99%